GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers

Clinical trial NCT03198052 · RECRUITING

Trial details

NCT number: NCT03198052
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer Cancer Immunotherapy CAR-T Cell

Start date: 2017-07-01
Primary completion: 2026-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.